Approach
Pipeline
Platform
About Us
Partners
Careers
News
Contact
Presentation
Poster
June
14
,
2025
EHA 2025: ALK1-BMPRII Receptor Agonism Treats Vascular Pathology in Hereditary Hemorrhagic Telangiectasia Models
Link to
Presentation
LINK TO VIDEO
LINK TO POSTER
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Accept